HQY vs. COLL
HQY (HealthEquity, Inc.) and COLL (Collegium Pharmaceutical, Inc.) are both stocks. Both are in the Healthcare sector — HQY in Health Information Services, COLL in Drug Manufacturers - Specialty & Generic. Over the past 10 years, HQY returned 12.32%/yr vs 6.77%/yr for COLL. At a 0.23 correlation, their price movements are largely independent.
Performance
HQY vs. COLL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HQY achieves a -6.99% return, which is significantly higher than COLL's -32.92% return. Over the past 10 years, HQY has outperformed COLL with an annualized return of 12.32%, while COLL has yielded a comparatively lower 6.77% annualized return.
HQY
- 1D
- -3.54%
- 1M
- 3.69%
- YTD
- -6.99%
- 6M
- -13.62%
- 1Y
- -17.88%
- 3Y*
- 12.87%
- 5Y*
- 0.99%
- 10Y*
- 12.32%
COLL
- 1D
- 1.90%
- 1M
- -10.18%
- YTD
- -32.92%
- 6M
- -35.09%
- 1Y
- 6.26%
- 3Y*
- 12.82%
- 5Y*
- 7.33%
- 10Y*
- 6.77%
HQY vs. COLL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HQY HealthEquity, Inc. | -6.99% | -4.52% | 44.72% | 7.56% | 39.33% | -36.54% | -5.89% | 24.17% | 27.84% | 15.15% |
COLL Collegium Pharmaceutical, Inc. | -32.92% | 61.61% | -6.92% | 32.67% | 24.20% | -6.74% | -2.67% | 19.86% | -6.99% | 18.56% |
Correlation
The correlation between HQY and COLL is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since May 8, 2015 | 0.23 |
Fundamentals
HQY:
$7.24B
COLL:
$1.24B
HQY:
$2.66
COLL:
$1.89
HQY:
32.06
COLL:
16.40
HQY:
0.23
COLL:
0.39
HQY:
5.53
COLL:
1.54
HQY:
3.54
COLL:
3.98
HQY:
$1.34B
COLL:
$796.33M
HQY:
$972.12M
COLL:
$483.18M
HQY:
$300.86M
COLL:
$550.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HQY vs. COLL — Risk / Return Rank
HQY
COLL
HQY vs. COLL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for HealthEquity, Inc. (HQY) and Collegium Pharmaceutical, Inc. (COLL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HQY | COLL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.65 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.06 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | -0.51 | 0.16 | -0.67 |
| Martin ratioReturn relative to average drawdown | -0.85 | 0.37 | -1.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HQY | COLL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.49 | 0.16 | -0.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.18 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | 0.13 | +0.15 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.15 | +0.17 |
Drawdowns
HQY vs. COLL - Drawdown Comparison
The maximum HQY drawdown since its inception was -60.65%, smaller than the maximum COLL drawdown of -73.59%. Use the drawdown chart below to compare losses from any high point for HQY and COLL.
Loading charts...
Drawdown Indicators
| HQY | COLL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.65% | -73.59% | +12.94% |
Max Drawdown (1Y)Largest decline over 1 year | -35.25% | -38.84% | +3.59% |
Max Drawdown (3Y)Largest decline over 3 years | -36.07% | -41.07% | +5.00% |
Max Drawdown (5Y)Largest decline over 5 years | -52.81% | -43.99% | -8.82% |
Max Drawdown (10Y)Largest decline over 10 years | -60.65% | -65.22% | +4.57% |
Current DrawdownCurrent decline from peak | -25.59% | -37.68% | +12.09% |
Average DrawdownAverage peak-to-trough decline | -22.98% | -31.17% | +8.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.15% | 16.99% | +4.16% |
Volatility
HQY vs. COLL - Volatility Comparison
The current volatility for HealthEquity, Inc. (HQY) is 10.40%, while Collegium Pharmaceutical, Inc. (COLL) has a volatility of 13.92%. This indicates that HQY experiences smaller price fluctuations and is considered to be less risky than COLL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HQY | COLL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.40% | 13.92% | -3.52% |
Volatility (6M)Calculated over the trailing 6-month period | 26.83% | 27.61% | -0.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.33% | 39.31% | -2.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.78% | 40.45% | -0.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.52% | 54.20% | -9.68% |
Dividends
HQY vs. COLL - Dividend Comparison
Neither HQY nor COLL has paid dividends to shareholders.
Financials
HQY vs. COLL - Financials Comparison
This section allows you to compare key financial metrics between HealthEquity, Inc. and Collegium Pharmaceutical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HQY vs. COLL - Profitability Comparison
HQY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HealthEquity, Inc. reported a gross profit of 256.31M and revenue of 354.64M. Therefore, the gross margin over that period was 72.3%.
COLL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Collegium Pharmaceutical, Inc. reported a gross profit of 117.25M and revenue of 193.52M. Therefore, the gross margin over that period was 60.6%.
HQY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HealthEquity, Inc. reported an operating income of 102.95M and revenue of 354.64M, resulting in an operating margin of 29.0%.
COLL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Collegium Pharmaceutical, Inc. reported an operating income of 30.90M and revenue of 193.52M, resulting in an operating margin of 16.0%.
HQY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HealthEquity, Inc. reported a net income of 69.42M and revenue of 354.64M, resulting in a net margin of 19.6%.
COLL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Collegium Pharmaceutical, Inc. reported a net income of 14.50M and revenue of 193.52M, resulting in a net margin of 7.5%.
Frequently Asked Questions
HQY and COLL have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
COLL has higher volatility (13.92%) compared to HQY (10.40%). In terms of maximum drawdown, HQY dropped -60.65% vs COLL's -73.59%.
COLL currently has the higher Sharpe Ratio (0.16 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HQY and COLL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer